Sewoon Medical Co., Ltd (KOSDAQ:100700)
South Korea
· Delayed Price · Currency is KRW 2,900.00
-10.00 (-0.34%)
At close: Apr 28, 2026
Sewoon Medical Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | 11,912 | 12,163 | 14,957 | 10,406 | 12,282 | Upgrade
|
| Depreciation & Amortization | 3,320 | 3,480 | 3,648 | 3,888 | 3,836 | Upgrade
|
| Loss (Gain) From Sale of Assets | -36.61 | -279.54 | -17.79 | -2.2 | 0.67 | Upgrade
|
| Asset Writedown & Restructuring Costs | -30.6 | - | -1.22 | 2 | -7.63 | Upgrade
|
| Provision & Write-off of Bad Debts | -3.54 | 7.31 | -1.25 | -15.31 | -22.77 | Upgrade
|
| Other Operating Activities | 1,822 | -2,201 | 2,807 | -1,861 | 2,413 | Upgrade
|
| Change in Accounts Receivable | -715.35 | 620.44 | 372.12 | -1,150 | 1,672 | Upgrade
|
| Change in Inventory | 1,121 | -1,268 | 203.91 | -1,177 | 2,077 | Upgrade
|
| Change in Accounts Payable | 305.51 | -356.95 | -92.73 | -418.94 | -271.82 | Upgrade
|
| Change in Other Net Operating Assets | 78.39 | 1,021 | 1,201 | -393.25 | -508.66 | Upgrade
|
| Operating Cash Flow | 17,773 | 13,186 | 23,076 | 9,279 | 21,469 | Upgrade
|
| Operating Cash Flow Growth | 34.79% | -42.86% | 148.71% | -56.78% | 11.52% | Upgrade
|
| Capital Expenditures | -1,691 | -1,435 | -1,949 | -2,151 | -2,224 | Upgrade
|
| Sale of Property, Plant & Equipment | 370.89 | 1,127 | 609.45 | 369.82 | 296.88 | Upgrade
|
| Sale (Purchase) of Intangibles | -8.8 | -216.2 | -6.59 | -17.12 | -265.02 | Upgrade
|
| Investment in Securities | - | 87.8 | 24,989 | -18,010 | -6,986 | Upgrade
|
| Other Investing Activities | 4 | 87.3 | 0.27 | -12.84 | 2 | Upgrade
|
| Investing Cash Flow | -1,324 | -349.15 | 23,642 | -19,821 | -9,177 | Upgrade
|
| Long-Term Debt Repaid | -252.41 | -254.62 | -295.87 | -297.92 | -275.49 | Upgrade
|
| Total Debt Repaid | -252.41 | -254.62 | -295.87 | -297.92 | -275.49 | Upgrade
|
| Net Debt Issued (Repaid) | -252.41 | -254.62 | -295.87 | -297.92 | -275.49 | Upgrade
|
| Repurchase of Common Stock | -2,988 | - | - | - | - | Upgrade
|
| Dividends Paid | -2,597 | -3,030 | -2,597 | -2,165 | -2,165 | Upgrade
|
| Financing Cash Flow | -5,838 | -3,285 | -2,893 | -2,462 | -2,440 | Upgrade
|
| Foreign Exchange Rate Adjustments | 314.5 | 836.78 | -118.43 | 156.3 | 361.33 | Upgrade
|
| Net Cash Flow | 10,926 | 10,388 | 43,707 | -12,849 | 10,213 | Upgrade
|
| Free Cash Flow | 16,083 | 11,750 | 21,127 | 7,128 | 19,244 | Upgrade
|
| Free Cash Flow Growth | 36.87% | -44.38% | 196.41% | -62.96% | 13.35% | Upgrade
|
| Free Cash Flow Margin | 25.26% | 19.54% | 30.96% | 11.86% | 30.75% | Upgrade
|
| Free Cash Flow Per Share | 376.68 | 271.47 | 488.02 | 164.65 | 444.53 | Upgrade
|
| Cash Interest Paid | 35.52 | 36.63 | - | - | - | Upgrade
|
| Cash Income Tax Paid | 1,823 | 4,696 | 2,360 | 4,920 | 1,410 | Upgrade
|
| Levered Free Cash Flow | 12,666 | 6,444 | 16,336 | 4,115 | 16,161 | Upgrade
|
| Unlevered Free Cash Flow | 12,689 | 6,467 | 16,358 | 4,137 | 16,180 | Upgrade
|
| Change in Working Capital | 789.45 | 16.18 | 1,685 | -3,139 | 2,968 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.